Sex-Specific Thresholds for Cardiac Biomarkers-We Need to Move Forward

Area of Science:

• Cardiology
• Biomarker Analysis
• Clinical Diagnostics

Background:

• Cardiovascular biomarkers are crucial for diagnosing and managing heart conditions.
• Current diagnostic practices often overlook sex-specific differences in biomarker thresholds.
• This oversight may limit the precision of prognostication and patient stratification.

Purpose of the Study:

• To review the evidence supporting the use of sex-specific cutoffs for cardiovascular biomarkers.
• To identify clinical situations where sex-specific thresholds offer diagnostic and prognostic advantages.
• To emphasize the importance of analyte-specific and indication-specific evaluation of sex-specific cutoffs.

Main Methods:

• Literature review of studies investigating sex-specific thresholds for cardiac biomarkers.
• Analysis of data demonstrating improved diagnostic discrimination and prognostication with sex-specific cutoffs.
• Focus on specific cardiac biomarkers and their clinical applications.

Main Results:

• Evidence indicates that sex-specific cutoffs enhance the performance of certain cardiovascular biomarkers.
• The utility of sex-specific thresholds varies depending on the biomarker and clinical context.
• Sex-specific values can improve risk stratification and diagnostic accuracy in specific patient populations.

Conclusions:

• The implementation of sex-specific cutoffs for cardiovascular biomarkers is beneficial in select clinical scenarios.
• Tailoring biomarker thresholds to sex can lead to more precise patient assessment.
• Further research and clinical adoption of sex-specific thresholds are warranted for optimized cardiovascular care.